Jackson C. Drolet

JACKSON DROLET focuses his practice on providing strategic advice on mergers and acquisitions and shareholder activism and corporate defense. He also advises on emerging companies and venture capital. 

Jackson has represented buyers, sellers, and targets in a broad range of public and private M&A transactions, including negotiated mergers, tender offers, and stock and asset purchases. His clients include strategic acquirers, private equity sponsors, and companies in the technology, life sciences, and healthcare sectors. Jackson is involved at every stage of a deal, from diligence through negotiation and signing of definitive agreements, and closing.

Jackson counsels public companies and their boards on corporate governance, fiduciary duties, SEC reporting and disclosure, stock exchange requirements, insider trading policies, and annual meeting and proxy matters. He also advises on shareholder activism and corporate defense, including activism preparedness, engagement with institutional investors, proxy contests, cooperation agreements, and responses to unsolicited proposals

Jackson earned his B.A. from the University of California, Berkeley, majoring in political economy and French.

• GE HealthCare (NASDAQ: GEHC) in its US$945 million acquisition of Sofie Biosciences, a radiopharmacy manufacturer.
• Jane Street in its investment in Fluidstack.
• GE HealthCare (NASDAQ: GEHC) in its US$2.3 billion acquisition of Intelerad, a medical imaging provider.
• Life360 (NASDAQ: LIF) in its $120 million acquisition of Nativo, an advertising technology company. 
• Cannae Holdings (NYSE: CNNE) in its activism campaign defense against Carronade Capital.
• Life360 (NASDAQ: LIF) in its US$275 million convertible senior note offering.
• MIPS in its merger with GlobalFoundries (NASDAQ: GFS).
• nCino (NASDAQ: NCNO) in connection with its cooperation agreement with HMI Capital.

• Represented a U.S. Navy veteran to upgrade their discharge characterization and narrative.